Profile of clinical trials with drugs for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in Spain
We conclude that there is a need to improve transparency, record all results- including negative ones- and review key aspects of design and funding, as recommendations for future research, including in health emergencies.
Authors
- María Serrano-Alonso (ORCID: https://orcid.org/0000-0003-1544-1055)
- Rafael Sánchez-del Hoyo (ORCID: https://orcid.org/0000-0002-3462-4183)
- Cristina González-Pérez
- María Pilar Suñé-Martín
- Eduardo Tejedor-Tejada
- María del Puy Goyache Goñi
Institutions
- Hospital Clínico San Carlos (ES)
- Hospital General De Segovia (ES)
- Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (ES)
- Hospital Universitario 12 De Octubre (ES)
- Vall d'Hebron Hospital Universitari (ES)
- Clinica Universidad de Navarra (ES)
- Universidad de Navarra (ES)
Publication Details
- Journal
- Farmacia Hospitalaria
- Published
- 2026-02-01
- DOI
- https://doi.org/10.1016/j.farma.2026.01.003
- Primary Topic
- COVID-19 Clinical Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00